2023-05-09T18:45:37-05:00 2022-12-31 410746749 CLIFTONLARSONALLEN LLP 1925 CENTURY PARK E 16TH FLOOR LOS ANGELES CA 90067 990 2022-01-01 954596354 TOWER CANCER RESEARCH FOUNDATION TOWE 3102998470 8767 WILSHIRE BLVD 401 BEVERLY HILLS CA 90211 STEVEN ABRAMSON EXECUTIVE DIRECTOR 3102998470 2023-05-08 1 STEVEN ABRAMSON 999009999 0 TAYIIKA M DENNIS CPA P01575149 3102732501 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z STEVEN ABRAMSON 8767 WILSHIRE BLVD 401 BEVERLY HILLS CA 90211 3446045 0 X TOWERCANCER.ORG X 1996 CA INNOVATIVE RESEARCH, COMMUNITY EDUCATION AND CARING PATIENT SUPPORT WHILE DEVELOPING MORE EFFECTIVE TREATMENTS FOR CANCER AND BLOOD DISORDERS. 29 29 16 0 0 0 3326155 3022740 0 0 56626 56004 -383783 -213019 2998998 2865725 1263968 902500 0 0 1085765 1168488 0 0 613298 1130929 1089753 3480662 3160741 -481664 -295016 3869425 4621629 1417410 2941048 2452015 1680581 X THROUGH LOCAL INVESTMENTS, WE ADVANCE GROUNDBREAKING CANCER RESEARCH AND PROFOUNDLY SUPPORT PEOPLE AFFECTED BY THE DISEASE TO CREATE OUTSIZED IMPACT IN SOUTHERN CALIFORNIA AND BEYOND. 0 0 2237998 902500 IN 2022, TOWER FUNDED ONE NEW SENIOR INVESTIGATOR SCIENTIFIC RESEARCH GRANT TO AN ESTEEMED RESEARCHER AT CITY OF HOPE RESEARCHING A NOVEL APPROACH TO ELICIT ANTI-TUMOR IMMUNITY AGAINST ACUTE MYELOID LEUKEMIA, A DISEASE THAT PATIENTS OFTEN EXPERIENCE POOR OUTCOMES. TOWER ALSO FUNDED TWO NEW CAREER DEVELOPMENT SCIENTIFIC RESEARCH GRANTS FOR TWO PROMISING YOUNG PHYSICIAN SCIENTISTS LOCATED AT UCSD. RESEARCH AREAS FOCUS ON INNOVATIVE THERAPIES THAT MAY REVEAL A NEW PARADIGM FOR HOW (SOLID) TUMORS ACQUIRE RESISTANCE TO THERAPY AND A NEW THERAPEUTIC STRATEGY TO TREAT DRUG RESISTANT CLL AND RELATED BLOOD CANCERS. IN ADDITION, TOWER CONTINUED FUNDING MULTI-YEAR SENIOR INVESTIGATOR GRANTS. TOTAL SCIENTIFIC GRANT EXPENDITURES IN 2022 TOPPED $1,100,000. INVESTING IN NOVEL IDEAS OF YOUNG INVESTIGATORS AND EXPERIENCED SENIOR INVESTIGATORS ALLOWS US TO LEVERAGE OUR DONOR DOLLARS TO HAVE MAXIMUM IMPACT. IN 2022 ALONE, TCRF RESEARCHERS REPORTED NEARLY $10M IN FOL-LOW-ON FUNDING, DOZENS OF GRANTS AND ACADEMIC AWARDS, TWO GROUNDBREAKING SCIENTIFIC DISCOVERIES, AND SO MUCH MORE.OUR CLINICALLY-GROUNDED SURVIVORSHIP SUPPORT PROGRAMS, HOSTED BY MAGNOLIA HOUSE, ALIGN WITH THE CHALLENG-ES FACED BY PATIENTS, SURVIVORS, AND THE WHOLE CANCER COMMUNITY. WE PROVIDE INTEGRATIVE HEALTH AND WELL-NESS SUPPORT AND EDUCATION, THROUGH FREE FITNESS, THERAPEUTIC, AND HOLISTIC CLASSES, THAT EMPOWERPEOPLE TO DEVELOP A PHYSICAL AND EMOTIONAL TOOLKIT TO MEET THE CHALLENGES OF CANCER FROM DIAGNOSIS TO SURVIVORSHIP. IN 2022, TOWER INVESTED OVER $500,000 IN SURVIVORSHIP PROGRAMS. IN 2013, MAGNOLIA HOUSE SURVIVORSHIP SUPPORT PROGRAM OFFERED 20 CLASSES AND HAD 500 VISITS IN THE FIRST YEAR. IN 2022, MAGNOLIA HOUSE OFFERED OVER 1500 CLASSES/SERVICES AND RECEIVED OVER 20,000 PARTICIPANT VISITS. IN RESPONSE TO COVID19, WE CONTINUED OFFERING CLASSES ONLINE VIA ZOOM WHICH HAS EXPANDED THE DEMOGRAPHICS IN WHICH WE SERVICE AND ENABLED US TO INCREASE OUR CLASS CAPACITIES. EVEN WITH AN INCREASE IN CLASS CAPACITIES, MANY OF OUR CLASSES HAD A WAIT LIST WHICH HIGHLIGHTS BOTH THE QUALITY IN THE PROGRAMS WE OFFER AND THE VOID THAT EXISTS, ESPECIALLY WITH THE ISOLATION MANY CANCER PATIENTS CONTINUE TO EXPERIENCE DUE TO COVID19. PARTICI-PANTS VIEW MAGNOLIA HOUSE SURVIVORSHIP SUPPORT PROGRAM AS A LIFELINE THAT PROVIDES NOT ONLY ENHANCED QUALITY OF LIFE BUT A COMMUNITY OF FRIENDSHIP, ENCOURAGEMENT, AND COMFORT AS WELL. ONE EXAMPLE THAT RE-FLECTS THE IMPACT OF MAGNOLIA HOUSE IS RECEIVING MULTIPLE DONATIONS FROM ONE GRATEFUL MAGNOLIA HOUSE PARTICIPANT THAT HAS TOTALED OVER $100,000 IN SUPPORT OF MAGNOLIA HOUSE. IT IS ONE OF THE LARGEST GIFTS FROM A MAGNOLIA HOUSE PARTICIPANT SINCE ITS INCEPTION. TOWER'S COMMUNITY PARTNERSHIP GRANT REVIEW COMMITTEE IS COMPOSED OF EXPERT VOLUNTEERS WHO REVIEW APPLICATIONS IN DEPTH AND THEN MEET TO DISCUSS GRANT APPLICATIONS FROM CANCER SUPPORT ORGANIZATIONS ACROSS SOUTHERN CALIFORNIA. IN 2022, WE FUNDED OVER $200,000 IN COMMUNITY PARTNER GRANTS AND CONTINUED TO RE-FINE OUR REVIEW PROCESS TO NOT ONLY INCLUDE IMPROVED METHODS OF REVIEWING, BUT ALSO REVISED THE ELIGIBILITY CRITERIA TO REFLECT A MORE TARGETED FOCUS ON FUNDING ORGANIZATIONS THAT SUPPORT UNDERSERVED AND UNDER RE-SOURCED COMMUNITIES ALLOWING US TO EXTEND OUR SUPPORT TO THOSE MOST IN NEED OF CARE. 2237998 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 0 1 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 44 0 1 16 1 0 0 0 0 0 1 0 0 0 0 0 0 0 X 29 29 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X STEVEN ABRAMSON 3102998470 8767 WILSHIRE BLVD 401 BEVERLY HILLS CA 90211 NANCY ROSENFELT CHAIRMAN OF THE BOARD 2.00 X X 0 0 0 LARRY ROSENSTEIN VICE CHAIR 2.00 X X 0 0 0 DONNA ROSEN PAST CHAIRMAN OF THE BOARD 2.00 X X 0 0 0 ABBY LEVY PAST CHAIRMAN OF THE BOARD 2.00 X 0 0 0 NANCY MISHKIN PAST CHAIRMAN OF THE BOARD 2.00 X 0 0 0 SOLOMON I HAMBURG MD PHD PRESIDENT 5.00 X X 0 0 0 DAVID SPINGARN TREASURER 2.00 X X 0 0 0 JEANNE SCHNITZER MARKS SECRETARY 2.00 X X 0 0 0 KELLY PRATHER MAGNOLIA COUNCIL PRESIDENT 2.00 X 0 0 0 FRED ROSENFELT MD VP SCIENTIFIC AFFAIRS 2.00 X 0 0 0 JONATHAN LAYNE DEVELOPMENT COMMITTEE CHAIRMAN 2.00 X 0 0 0 SHELLEY WARSAVSKY DIRECTOR 2.00 X 0 0 0 ELIZABETH DRUCKER DIRECTOR 2.00 X 0 0 0 KAREN ROSENFELT BLANCATO DIRECTOR 2.00 X 0 0 0 HILTON CHODOROW DIRECTOR 2.00 X 0 0 0 ROBERT DECKER MD DIRECTOR 2.00 X 0 0 0 LINDA LEVENSON DELSACK DIRECTOR 2.00 X 0 0 0 BETTY HAAGEN DIRECTOR 2.00 X 0 0 0 CASEY FEDERMAN DIRECTOR 2.00 X 0 0 0 KATHY GALLAGHER DIRECTOR 2.00 X 0 0 0 RANDY KATZ DIRECTOR 2.00 X 0 0 0 BETH GOREN DIRECTOR 2.00 X 0 0 0 SUSAN KREVOY PHD DIRECTOR 2.00 X 0 0 0 FRANKIE SHOLEM DIRECTOR 2.00 X 0 0 0 ALAN D LEVY DIRECTOR 2.00 X 0 0 0 SALLY MAGARAM DIRECTOR 2.00 X 0 0 0 PHILOMENA MCANDREW MD DIRECTOR 2.00 X 0 0 0 BARRY ROSENBLOOM MD DIRECTOR 2.00 X 0 0 0 JOHN CARPTEN PHD DIRECTOR 2.00 X 0 0 0 STEVEN ABRAMSON EXECUTIVE DIRECTOR 40.00 X X 61925 0 1390 KELLI SARGENT DEPUTY DIRECTOR 40.00 X 105199 0 9163 ANN SPURGEON CDO 40.00 X 115504 0 17416 LINDA DAVID FORMER EXECUTIVE DIRECTOR 40.00 X 178145 0 29366 460773 0 57335 5 1 1 0 0 1802955 1219785 3022740 56004 56004 156700 1802955 580320 -423620 -423620 ERC 900099 210601 210601 210601 2865725 0 0 -157015 902500 902500 68783 27513 13757 27513 908502 402437 142664 363401 116029 51108 18509 46412 75174 33077 12028 30069 6240 755 4885 600 38748 4688 30331 3729 7074 856 5537 681 37225 24127 3723 9375 50278 23835 6219 20224 63271 47453 6327 9491 533463 400098 53346 80019 3600 724 361 2515 100236 75177 10024 15035 27649 24675 1487 1487 OUTREACH PROGRAMS 219716 218975 247 494 FUNDRAISING EXPENSE 2253 2253 3160741 2237998 309445 613298 582065 529067 346450 271750 64857 63500 1275572 978277 387563 297295 2488490 2301569 0 1158448 3869425 4621629 117410 107461 1300000 2833587 1417410 2941048 X 885343 569738 1566672 1110843 2452015 1680581 3869425 4621629 -295016 -476418 0 X X 0 1 X 1 0 X 3720525 4097941 2679554 3336155 3022740 16856915 3720525 4097941 2679554 3336155 3022740 16856915 483772 16373143 39144 44603 44531 56626 56004 240908 17097823 870751 0.95760 0.95930 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 883113 607509 275604 392459 370768 21691 297295 OPERATING ROU ASSET 1152194 FINANCING ROU ASSET 6254 1158448 PLEDGES PAYABLE 1675000 OPERATING LEASE LIABILITY 1152194 FINANCING LEASE LIABILITY 6393 2833587 X 2969627 -476418 580320 103902 2865725 0 2865725 3741061 580320 580320 3160741 0 3160741 PART X, LINE 2: TOWER CANCER RESEARCH FOUNDATION FILES IRS FORM 990 AND STATE FORMS 199 AND RRF-1. ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA PROVIDE ACCOUNTING AND DISCLOSURE GUIDANCE ABOUT POSITIONS TAKEN BY AN ORGANIZATION IN ITS TAX RETURNS THAT MIGHT BE UNCERTAIN. TOWER CANCER RESEARCH FOUNDATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. MANAGEMENT OF TOWER CANCER RESEARCH FOUNDATION DOES NOT BELIEVE THE FINANCIAL STATEMENTS INCLUDE ANY UNCERTAIN TAX POSITIONS. PART XI, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSE 580,320. PART XII, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSE 580,320. GALA 903304 870305 32999 98953 112007 GOLF 398236 301936 96300 20734 200732 1 658115 630715 27400 54577 93318 1959655 1802956 156699 174264 406057 580321 -423622 0 BREAST CANCER ANGELS PO BOX 340 LOS ALAMITOS CA 90720 330937846 501C3 20000 0 COMMUNITY OUTREACH BUMBLE BEE FOUNDATION 4035 E THOUSAND OAKS BLVD STE 235 THOUSAND OAKS CA 91362 452442151 501C3 15000 0 COMMUNITY OUTREACH DISABILITY RIGHTS LEGAL CENTER 1541 WILSHIRE BLVD 400 LOS ANGELES CA 90017 952960607 501C3 10000 0 COMMUNITY OUTREACH OUR HOUSE 1663 SAWTELLE BLVD SUITE 300 LOS ANGELES CA 90025 330529915 501C3 25000 0 COMMUNITY OUTREACH PROJECT ANGEL FOOD 922 VINE STREET LOS ANGELES CA 90038 954115863 501C3 30000 0 COMMUNITY OUTREACH VIETNAMESE AMERICAN CANCER FOUNDATION 17150 NEWHOPE ST 203 FOUNTAIN VALLEY CA 92708 912170415 501C3 20000 0 COMMUNITY OUTREACH HEALING ODYSSEY INC 23785 EL TORO RD 199 LAKE FOREST CA 92630 352533287 501C3 7500 0 COMMUNITY OUTREACH CANCER KINSHIP 1901 E FOURTH ST STE 100 SANTA ANA CA 92705 952021700 501C3 15000 0 COMMUNITY OUTREACH TRIAGE CANCER 18203 KINGSPORT DR MALIBU CA 90265 455132661 501C3 10000 0 COMMUNITY OUTREACH WOMEN OF COLOR BREAST CANCER SURVIVORS' SUPPORT PROJECT PO BOX 9026 INGLEWOOD CA 90305 954455930 501C3 47500 0 COMMUNITY OUTREACH CITY OF HOPE 1500 EAST DUARTE ROAD DUARTE CA 91010 953435919 501C3 500000 0 RESEARCH GRANT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO 9500 GILMAN DRIVE LA JOLLA CA 92093 956006144 501C3 200000 0 RESEARCH GRANT 13 0 X 0 0 0 0 0 0 0 0 0 LINDA DAVID FORMER EXECUTIVE DIRECTOR 178145 0 0 0 0 0 0 0 29366 0 207511 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 MARRIED COUPLES: ALAN D & ABBY LEVY FRED & NANCY ROSENFELT FORM 990, PART VI, SECTION B, LINE 11B REVIEW OF FORM 990 PRIOR TO FILING FORM 990, PART VI, SECTION B, LINE 12C CONSISTENT MONITORING AND ENFORCEMENT FORM 990, PART VI, SECTION B, LINE 15 REVIEW AND APPROVAL BY BOARD OF DIRECTORS FORM 990, PART VI, SECTION C, LINE 19 AVAILABLE UPON REQUEST PART X11, LINE 2C THE ORGANIZATION'S EXECUTIVE COMMITTEE ASSUMES OVERSIGHT OVER THE AUDIT PROCESS AND REVIEWS AND APPROVES THE AUDIT. THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.